ALC-0159 NEW
Price | $55 | $89 | $155 |
Package | 5mg | 10mg | 25mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2024-11-13 |
Product Details
Product Name: ALC-0159 | CAS No.: 1849616-42-7 |
Purity: polymer | Supply Ability: 10g |
Release date: 2024/11/13 |
Product Introduction
Bioactivity
名稱 | ALC-0159 |
描述 | ALC-0159 is a polyethylene glycol (PEG) lipid conjugate that could be used as a vaccine excipient[1]. |
體外活性 | ALC-0159 promotes nanoparticle stabilization by a steric mechanism through its poly(ethylene glycol) (PEG) moiety[1]. |
存儲(chǔ)條件 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 18.33 mg/mL (33.77 mM), Sonication is recommended. |
關(guān)鍵字 | ALC 0159 | conjugate | lipid | ALC-0159 | vaccine | inhibit | excipient | Inhibitor | ALC0159 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$0.00/1g |
VIP4Y
|
XIAMEN SINOPEG BIOTECH CO., LTD.
|
2024-07-26 | |
$0.00/1kg |
henan kanbei chemical co.,ltd
|
2022-09-19 | ||
$0.00/1g |
VIP4Y
|
XIAMEN SINOPEG BIOTECH CO., LTD.
|
2021-06-22 | |
$0.00/1G |
VIP4Y
|
XIAMEN SINOPEG BIOTECH CO., LTD.
|
2021-06-01 |
- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY